ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.331,39
-0,25%
S&P 500
5.469,30
0,39%
US Dollar vs BRL
5,4522
0,00%
Bitcoin
61.566,77
-0,38%
Brent Oil
84,695
0,61%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. JanOne Inc (JAN)

  7. JanOne Inc (JAN) Notícias

JAN

JanOne (JAN)

JanOne Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:JAN
DataHoraFonteTítuloCódigoCompanhia
25/06/202408:30PR Newswire (US)ALT5 SIGMA, A JANONE COMPANY, ADDS PREPAID VISA®️ CARD INTEGRATION TO ALT5 SETTLEMENT PLATFORMNASDAQ:JANJanOne Inc
13/06/202408:30PR Newswire (US)JanOne's Subsidiary, Alt5, Reports 91% year over year increase in Transaction Volume to US $289 million for April and May 2024NASDAQ:JANJanOne Inc
11/06/202409:30PR Newswire (US)ALT5 Sigma, a wholly-owned subsidiary of JanOne, Launches ALT5 Settlement Platform aimed at the untapped $27.3 Billion Global Digital Content Creation MarketNASDAQ:JANJanOne Inc
05/06/202416:50Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:JANJanOne Inc
04/06/202418:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:JANJanOne Inc
03/06/202413:05PR Newswire (US)JanOne Inc. added to the Russell Microcap® IndexNASDAQ:JANJanOne Inc
23/05/202418:02Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:JANJanOne Inc
16/05/202417:00PR Newswire (US)JanOne Closes Acquisition of ALT 5 Sigma Inc., a Leading Next Generation Blockchain FintechNASDAQ:JANJanOne Inc
13/05/202408:30PR Newswire (US)JanOne to Acquire ALT 5 Sigma Inc., a Leading Next Generation Blockchain Financial Technology ProviderNASDAQ:JANJanOne Inc
15/03/202410:00PR Newswire (US)JanOne Regains Compliance with Nasdaq's Listing RequirementsNASDAQ:JANJanOne Inc
21/09/202312:30PR Newswire (US)JanOne to Present at the Dawson James 8th Annual Investment ConferenceNASDAQ:JANJanOne Inc
21/09/202310:35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceNASDAQ:JANJanOne Inc
31/08/202314:30PR Newswire (US)JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment ConferenceNASDAQ:JANJanOne Inc
29/08/202314:30PR Newswire (US)JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic PainNASDAQ:JANJanOne Inc
28/08/202318:20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:JANJanOne Inc
25/08/202315:30PR Newswire (US)JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual MeetingNASDAQ:JANJanOne Inc
24/08/202317:30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:JANJanOne Inc
22/08/202318:30PR Newswire (US)JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq RulesNASDAQ:JANJanOne Inc
18/08/202320:00PR Newswire (US)JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq RulesNASDAQ:JANJanOne Inc
18/08/202313:42PR Newswire (US)JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual MeetingNASDAQ:JANJanOne Inc
16/08/202316:55Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:JANJanOne Inc
15/08/202317:39Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:JANJanOne Inc
28/06/202309:30PR Newswire (US)JanOne files international patent application for methods of using low dose naltrexone to treat chronic painNASDAQ:JANJanOne Inc
22/05/202317:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:JANJanOne Inc
11/05/202317:31Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:JANJanOne Inc
21/04/202317:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JANJanOne Inc
18/04/202309:30PR Newswire (US)JanOne Completes Pre-IND Meeting with FDA on Jan123NASDAQ:JANJanOne Inc
17/04/202317:58Edgar (US Regulatory)Annual Report (10-k)NASDAQ:JANJanOne Inc
13/04/202309:30PR Newswire (US)JanOne to Present Data On Its Two Non-Opioid Drug Candidates at The Appalachian Region Spine and Pain Meeting on Drug Development Programs to Treat Pain on April 15, 2023NASDAQ:JANJanOne Inc
27/03/202310:01Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:JANJanOne Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:JAN

Seu Histórico Recente

AMEX
QEE
Queenstake
TG
A351U0
Bayer
KUCN
WAXPETH
WAX Protocol Tokens
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados